Neurology Conference Presentations Hub

Welcome to our Neurology Conference Presentations Hub, a dedicated space with access to the presentations Sangamo delivers at industry leading conferences. Learn about our latest preclinical research and results while gaining insights into our wealth of neurology knowledge.

Chronic Neuropathic Pain
Prion
Viral Engineering for CNS Delivery: Intravenous Delivery
Viral Engineering for CNS Delivery: Intrathecal Delivery
Tauopathies
Synucleinopathies
Amyotrophic Lateral Sclerosis (ALS)
Neurodevelopmental Disorders
Neuromuscular Disorders
Huntington’s Disease

Chronic Neuropathic Pain

ASGCT 2026

Poster: ST-503 nonclinical safety studies evaluating zinc finger repressors regulating expression of the Nav1.7 gene for treatment of small fiber neuropathy
Science Translational Medicine

Engineered zinc finger repressors induce a prolonged and selective repression of SCN9A in nociceptors of nonhuman primates
9th International Congress on Neuropathic Pain

Poster: Preclinical Development of ST-503: an Investigational Adeno-associated Viral Vector Delivered Zinc Finger Repressor Novel Epigenetic Therapy for Idiopathic Small Fiber Neuropathy
ASGCT 2025

Presentation: AAV-Mediated Delivery of an Engineered Zinc Finger Lead to Selective and Potent Repression of Nav1.7 in Human Sensory Neurons and Nonhuman Primates DRG Nociceptors Following Intrathecal Injection
CRL Biotechnology Symposium 2023

Preclinical Development of a Zinc Finger Transcriptional Repressor Targeting the SCN9A Gene as a Novel Therapy for Peripheral Neuropathic Pain
American College of Toxicology 2023

Preclinical Development of a Novel Gene Therapy for the Treatment of Peripheral Neuropathic Pain Through Zinc Finger Repressor- Mediated Repression of the SCN9A Gene
Annual Pain Therapeutics Summit 2023

Zinc finger mediated epigenetic repression of SCN9A gene as a therapeutic approach for painful peripheral neuropathies

Prion

LinkedIn Webinar 2025

Viral Engineering for CNS Delivery: Intravenous Delivery

Viral Engineering for CNS Delivery: Intrathecal Delivery

Tauopathies

Synucleinopathies

Amyotrophic Lateral Sclerosis (ALS)

Neurodevelopmental Disorders

Neuromuscular Disorders

Huntington’s Disease

Nature Medicine

Allele-selective transcriptional repression of mutant HTT for the treatment of Huntington’s disease

Sangamo enters into asset sale agreements with Lilly and Astellas

Additional information about the Chapter 11 reorganization and asset sales is available through Sangamo's noticing agent at https://www.veritaglobal.net/SangamoTherapeutics.

Neurology Conference Presentations Hub

LinkedIn Webinar 2025